Landos Biopharma, Inc.
Lanthionine synthetase C-like 2-based therapeutics

Abstract:

Provided are compounds that target the lanthionine synthetase C-like protein 2 pathway. The compounds can be used to treat a number of conditions, including infectious disease, autoimmune disease, diabetes, and a chronic inflammatory disease.